흑색종 치료제 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 치료법별, 질환 유형별, 용도별, 지역별, 경쟁별 세분화(2020-2030년)
Melanoma Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy, By Disease Type, By Application, By Region and Competition, 2020-2030F
상품코드:1886419
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 흑색종 치료제 시장은 2024년 74억 2,000만 달러에서 2030년까지 119억 8,000만 달러로, CAGR 8.31%로 성장할 것으로 예측됩니다. 흑색종 치료제는 악성 세포의 증식과 확산을 표적화하여 억제함으로써 악성도가 높은 피부암인 흑색종 치료를 목적으로 개발된 의약품을 말합니다. 시장 성장은 주로 전 세계 흑색종 발생률 증가와 질병을 조기에 발견할 수 있는 진단 기술의 발전으로 인해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
74억 2,000만 달러
시장 규모 : 2030년
119억 8,000만 달러
CAGR : 2025-2030년
8.31%
가장 빠르게 성장하는 부문
면역치료
최대 시장
북미
주요 시장 성장 촉진요인
세계에서 증가하고 있는 흑색종 발생률은 흑색종 치료제 시장의 기본적인 촉진요인입니다. 진단 건수 증가는 치료적 개입이 필요한 환자층을 직접적으로 확대하여 효과적인 치료법에 대한 수요를 증가시키고 있습니다.
주요 시장 과제
혁신적인 흑색종 치료에 따른 막대한 비용은 세계 흑색종 치료제 시장의 성장에 큰 장벽이 되고 있습니다. 새로운 표적치료제와 면역치료제의 높은 가격은 환자의 접근성과 의료시스템의 지속가능성에 직접적인 영향을 미치고 있습니다.
주요 시장 동향
세계 흑색종 치료제 시장에서 눈에 띄는 동향은 다제 병용요법 및 복합요법으로의 전환을 꼽을 수 있습니다. 이러한 치료법은 효과와 환자 예후를 개선하는 것으로 나타났습니다. 이 접근법에서는 면역치료제와 표적치료제 등 다양한 치료법을 결합하여 여러 기전을 통해 동시에 암세포를 공격하는 방식입니다. 이를 통해 내성을 극복하고 생존 기간을 연장할 수 있습니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 흑색종 치료제 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
치료법별(화학요법, 면역치료, 표적치료)
질환 유형별(표재성 흑색종, 악성 흑자, 선단 흑자성 흑색종, 결절성 흑색종)
용도별(병원, 외래 종양과클리닉, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 흑색종 치료제 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 흑색종 치료제 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 흑색종 치료제 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 흑색종 치료제 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 흑색종 치료제 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 흑색종 치료제 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Bristol-Myers Squibb Company
AstraZeneca PLC
Amgen Inc.
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Merck & Co. Inc
Abbott Laboratories Inc.
Bayer AG
Aptose Biosciences Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Melanoma Drugs Market will grow from USD 7.42 Billion in 2024 to USD 11.98 Billion by 2030 at a 8.31% CAGR. Melanoma drugs refer to pharmaceutical agents developed to treat melanoma, an aggressive form of skin cancer, by targeting and inhibiting the proliferation and spread of malignant cells. The market's growth is predominantly driven by the increasing global incidence of melanoma and advancements in diagnostic technologies enabling earlier disease detection.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 7.42 Billion
Market Size 2030
USD 11.98 Billion
CAGR 2025-2030
8.31%
Fastest Growing Segment
Immunotherapy
Largest Market
North America
Key Market Drivers
The increasing incidence of melanoma globally represents a fundamental driver for the melanoma drugs market. The rise in diagnoses directly expands the patient pool requiring therapeutic intervention, thereby escalating demand for effective treatments. According to the American Cancer Society, in February 2025, an estimated 104,960 new cases of invasive melanoma are expected to be diagnosed in the United States this year. This growing patient demographic underscores the urgent need for a continuous supply of both existing and novel pharmaceutical solutions. Factors such as increased ultraviolet radiation exposure and improved diagnostic capabilities contribute to these rising numbers, highlighting a persistent and evolving challenge in public health that fuels market expansion.
Key Market Challenges
The substantial cost associated with innovative melanoma treatments represents a significant impediment to the growth of the global melanoma drugs market. The high pricing of novel targeted therapies and immunotherapies directly impacts patient access and the overall sustainability of healthcare systems. This financial burden, often termed financial toxicity, can lead to reduced treatment initiation and adherence, even for life-extending medications.
Key Market Trends
A significant trend in the global melanoma drugs market is the shift towards multi-modal and combination therapies, which are demonstrating enhanced efficacy and improved patient outcomes. This approach involves combining different therapeutic modalities, such as immunotherapies with targeted agents, to attack cancer cells through multiple mechanisms simultaneously, thereby overcoming resistance and extending survival.
Key Market Players
Bristol-Myers Squibb Company
AstraZeneca PLC
Amgen Inc.
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Merck & Co. Inc
Abbott Laboratories Inc.
Bayer AG
Aptose Biosciences Inc.
Report Scope:
In this report, the Global Melanoma Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Melanoma Drugs Market, By Therapy:
Chemotherapy
Immunotherapy
Targeted Therapy
Melanoma Drugs Market, By Disease Type:
Superficial Spreading Melanoma
Lentigo Maligna
Acral Lentiginous Melanoma
Nodular Melanoma
Melanoma Drugs Market, By Application:
Hospitals
Outpatient Oncologist Clinics
Others
Melanoma Drugs Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Melanoma Drugs Market.
Available Customizations:
Global Melanoma Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Melanoma Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy)
5.2.2. By Disease Type (Superficial Spreading Melanoma, Lentigo Maligna, Acral Lentiginous Melanoma, Nodular Melanoma)
5.2.3. By Application (Hospitals, Outpatient Oncologist Clinics, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Melanoma Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy
6.2.2. By Disease Type
6.2.3. By Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Melanoma Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapy
6.3.1.2.2. By Disease Type
6.3.1.2.3. By Application
6.3.2. Canada Melanoma Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapy
6.3.2.2.2. By Disease Type
6.3.2.2.3. By Application
6.3.3. Mexico Melanoma Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapy
6.3.3.2.2. By Disease Type
6.3.3.2.3. By Application
7. Europe Melanoma Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Disease Type
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Melanoma Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy
7.3.1.2.2. By Disease Type
7.3.1.2.3. By Application
7.3.2. France Melanoma Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy
7.3.2.2.2. By Disease Type
7.3.2.2.3. By Application
7.3.3. United Kingdom Melanoma Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy
7.3.3.2.2. By Disease Type
7.3.3.2.3. By Application
7.3.4. Italy Melanoma Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapy
7.3.4.2.2. By Disease Type
7.3.4.2.3. By Application
7.3.5. Spain Melanoma Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapy
7.3.5.2.2. By Disease Type
7.3.5.2.3. By Application
8. Asia Pacific Melanoma Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Disease Type
8.2.3. By Application
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Melanoma Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Disease Type
8.3.1.2.3. By Application
8.3.2. India Melanoma Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Disease Type
8.3.2.2.3. By Application
8.3.3. Japan Melanoma Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Disease Type
8.3.3.2.3. By Application
8.3.4. South Korea Melanoma Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy
8.3.4.2.2. By Disease Type
8.3.4.2.3. By Application
8.3.5. Australia Melanoma Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy
8.3.5.2.2. By Disease Type
8.3.5.2.3. By Application
9. Middle East & Africa Melanoma Drugs Market Outlook
